Home > Riviste > The Journal of Cardiovascular Surgery > Fascicoli precedenti > The Journal of Cardiovascular Surgery 2013 June;54(3) > The Journal of Cardiovascular Surgery 2013 June;54(3):333-6

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

THE JOURNAL OF CARDIOVASCULAR SURGERY

Rivista di Chirurgia Cardiaca, Vascolare e Toracica


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,632


eTOC

 

  INNOVATIONS IN DRUG-ELUTING TECHNOLOGY


The Journal of Cardiovascular Surgery 2013 June;54(3):333-6

lingua: Inglese

Femoropopliteal in-stent restenosis: review and potential for drug based therapy

Phillips J. 1, Ansel G. 2

1 Cardiology, Internal Medicine Ohio Health Riverside Methodist Hospital Columbus, OH, USA;
2 Cardiology, Internal Medicine Ohio Health Riverside Methodist Hospital Columbus, OH, USA


PDF  


Endovascular treatment of symptomatic peripheral arterial disease in the femoropopliteal (FP) artery is fraught with high rates of restenosis. Success of the antiproliferative drug, paclitaxel, in the coronary arteries, has lead to the investigation of paclitaxel in the peripheral arteries to treat restenosis. This article reviews restenosis rates for the major treatment modalities used in the FP segment. Use of drug-elution for restenosis is also reviewed, including the use of drug-eluting balloons and drug-eluting stents.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

gansel2@ohiohealth.com